These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23029682)

  • 21. Poor countries should use flexibility in global trade agreement to improve access to antiretrovirals, says report.
    Zarocostas J
    BMJ; 2011 Mar; 342():d1677. PubMed ID: 21411492
    [No Abstract]   [Full Text] [Related]  

  • 22. The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.
    Torres MA
    Chic J Int Law; 2002; 3(1):105-14. PubMed ID: 15709302
    [No Abstract]   [Full Text] [Related]  

  • 23. Funding for HIV/AIDS needs to double to ensure universal access to drugs.
    Dyer C
    BMJ; 2009 Feb; 338():b583. PubMed ID: 19211637
    [No Abstract]   [Full Text] [Related]  

  • 24. Learning and doing: operational research and access to HIV treatment in Africa.
    Katzenstein D; Koulla-Shiro S; Laga M; Moatti JP
    AIDS; 2010 Jan; 24 Suppl 1():S1-4. PubMed ID: 20023435
    [No Abstract]   [Full Text] [Related]  

  • 25. Africa access: moving fast, outcome uncertain.
    James JS
    AIDS Treat News; 2001 Feb; (360):4-8. PubMed ID: 12173567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for the developing world.
    GMHC Treat Issues; 1997-1998 Winter; 12(1):32. PubMed ID: 11364989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The promise of ADAP.
    Montgomery M
    Focus; 2007 Jan; 22(1):4-6. PubMed ID: 17526106
    [No Abstract]   [Full Text] [Related]  

  • 28. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 29. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 30. Expansion of global access to HIV/AIDS treatment.
    Public Health Rep; 2002; 117(6):592. PubMed ID: 12599369
    [No Abstract]   [Full Text] [Related]  

  • 31. $15 million for infrastructure but no AIDS drugs for Jamaica.
    GMHC Treat Issues; 2003 Mar; 17(3):9-10. PubMed ID: 12728859
    [No Abstract]   [Full Text] [Related]  

  • 32. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

  • 33. The evaluation of the HIV/AIDS drug access initiatives in Côte d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa.
    Katzenstein D; Laga M; Moatti JP
    AIDS; 2003 Jul; 17 Suppl 3():S1-4. PubMed ID: 14565603
    [No Abstract]   [Full Text] [Related]  

  • 34. Global good news: many more treated.
    AIDS Treat News; 2005 Jan; (409):6-7. PubMed ID: 15791715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International. Rights group: U.S. blocking access to generic AIDS drugs.
    AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
    [No Abstract]   [Full Text] [Related]  

  • 36. Universal access to antiretroviral therapy: are we moving the targets?
    Ndumbe PM
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(6):279-80. PubMed ID: 19164137
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fourth French-speaking HIV-AIDS conference, difficult access to drugs in the southern countries].
    Gabillat C
    Soins; 2007; (717):16. PubMed ID: 17877244
    [No Abstract]   [Full Text] [Related]  

  • 38. Sending HIV drugs to developing countries.
    Arboleda CH
    GMHC Treat Issues; 1998 Jun; 12(6):7-8. PubMed ID: 11365724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection.
    Maher D; von Schoen-Angerer T; Cohn J
    Int J Clin Pract; 2011 Aug; 65(8):824-7. PubMed ID: 21762306
    [No Abstract]   [Full Text] [Related]  

  • 40. Expanded and early access and patient assistance programs for other experimental drugs from their manufacturers.
    Crit Path AIDS Proj; 1998; (No 33):43-64. PubMed ID: 11366373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.